42nd FDA Boot Camp

42nd FDA Boot Camp

New York, NY
Speaking Engagement

The American Conference Institute’s FDA Boot Camp returns for its 42nd iteration continuing to provide the working knowledge of the core essentials of FDA law and regulation, including the new amendments under the Food and Drug Omnibus Reform Act (FDORA). A distinguished faculty of top FDA regulatory authorities—a “Who’s Who of the FDA Bar”—will share their knowledge and provide critical insights throughout the event’s workshops.

On Thursday, March 14, WilmerHale Partner Christopher Noyes will lead the “Hatch-Waxman and BPCIA in the Trenches: Exclusivity and Bioequivalency Working Group” workshop, building upon the content covered during the main conference on the regulatory and IP interplay in the Hatch-Waxman and Biologics Price Competition and Innovation Act schematics.

Read More About the Event



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.